1. Home
  2. SLRX vs JZXN Comparison

SLRX vs JZXN Comparison

Compare SLRX & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • JZXN
  • Stock Information
  • Founded
  • SLRX N/A
  • JZXN 2019
  • Country
  • SLRX United States
  • JZXN China
  • Employees
  • SLRX N/A
  • JZXN N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • JZXN Retail-Auto Dealers and Gas Stations
  • Sector
  • SLRX Health Care
  • JZXN Consumer Discretionary
  • Exchange
  • SLRX Nasdaq
  • JZXN Nasdaq
  • Market Cap
  • SLRX 2.9M
  • JZXN 51.8M
  • IPO Year
  • SLRX N/A
  • JZXN 2021
  • Fundamental
  • Price
  • SLRX $5.56
  • JZXN $1.00
  • Analyst Decision
  • SLRX
  • JZXN
  • Analyst Count
  • SLRX 0
  • JZXN 0
  • Target Price
  • SLRX N/A
  • JZXN N/A
  • AVG Volume (30 Days)
  • SLRX 286.4K
  • JZXN 248.5K
  • Earning Date
  • SLRX 11-13-2025
  • JZXN 03-05-2026
  • Dividend Yield
  • SLRX N/A
  • JZXN N/A
  • EPS Growth
  • SLRX N/A
  • JZXN N/A
  • EPS
  • SLRX N/A
  • JZXN N/A
  • Revenue
  • SLRX N/A
  • JZXN $97,465.00
  • Revenue This Year
  • SLRX N/A
  • JZXN N/A
  • Revenue Next Year
  • SLRX N/A
  • JZXN N/A
  • P/E Ratio
  • SLRX N/A
  • JZXN N/A
  • Revenue Growth
  • SLRX N/A
  • JZXN N/A
  • 52 Week Low
  • SLRX $4.50
  • JZXN $0.78
  • 52 Week High
  • SLRX $108.00
  • JZXN $7.82
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 43.47
  • JZXN 54.31
  • Support Level
  • SLRX $4.79
  • JZXN $0.95
  • Resistance Level
  • SLRX $5.90
  • JZXN $1.11
  • Average True Range (ATR)
  • SLRX 0.40
  • JZXN 0.07
  • MACD
  • SLRX 0.27
  • JZXN 0.03
  • Stochastic Oscillator
  • SLRX 75.36
  • JZXN 64.71

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About JZXN Jiuzi Holdings Inc.

Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.

Share on Social Networks: